| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
CDKN2B antisense RNA 1 | 0.491 | 0.769 |
|
disease | 0.160 | None | 0.917 | 12 | 19 | 2009 | 2019 | |||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
disease | 0.500 | None | 0.991 | 215 | 12 | 1988 | 2020 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.900 | None | 0.946 | 205 | 11 | 1991 | 2020 | ||||||||
|
CCDC26 long non-coding RNA | 0.647 | 0.615 |
|
disease | 0.500 | None | 1.000 | 18 | 10 | 2009 | 2020 | |||||||||
|
X-ray repair cross complementing 1 | 0.421 | 0.923 | 6.3E-09 |
|
disease | 0.400 | None | 0.893 | 28 | 9 | 2007 | 2019 | ||||||||
|
pleckstrin homology like domain family B member 1 | 0.722 | 0.423 | 0.11 |
|
disease | 0.500 | None | 1.000 | 21 | 7 | 2009 | 2020 | ||||||||
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
disease | 0.100 | None | 0.962 | 104 | 6 | 1994 | 2019 | ||||||||
|
O-6-methylguanine-DNA methyltransferase | 0.412 | 0.885 | 1.2E-07 |
|
disease | 0.400 | None | 0.980 | 100 | 6 | 1991 | 2020 | ||||||||
|
regulator of telomere elongation helicase 1 | 0.459 | 0.808 | 8.9E-10 |
|
disease | 0.500 | None | 1.000 | 32 | 6 | 2009 | 2020 | ||||||||
|
RTEL1-TNFRSF6B readthrough (NMD candidate) | 0.682 | 0.385 |
|
disease | 0.100 | None | 1.000 | 9 | 6 | 2009 | 2019 | |||||||||
|
EGF containing fibulin extracellular matrix protein 1 | 0.540 | 0.769 | 1.00 |
|
disease | 0.080 | None | 1.000 | 8 | 6 | 2009 | 2017 | ||||||||
|
annexin A5 | 0.458 | 0.769 | 3.8E-15 |
|
disease | 0.060 | None | 1.000 | 6 | 6 | 2006 | 2019 | ||||||||
|
MIR3142 host gene | 1.000 | 0.038 |
|
disease | 0.010 | None | 1.000 | 1 | 6 | 2020 | 2020 | |||||||||
|
telomerase reverse transcriptase | 0.374 | 0.846 | 0.99 |
|
disease | 0.400 | None | 0.979 | 48 | 5 | 2004 | 2019 | ||||||||
|
mastermind like transcriptional coactivator 2 | 0.592 | 0.577 | 1.00 |
|
disease | 0.110 | None | 1.000 | 2 | 5 | 2017 | 2019 | ||||||||
|
N-myc and STAT interactor | 0.656 | 0.346 | 8.7E-06 |
|
disease | 0.020 | None | 1.000 | 2 | 5 | 2015 | 2015 | ||||||||
|
phosphatase and tensin homolog | 0.305 | 0.923 | 0.26 |
|
disease | 0.700 | None | 0.972 | 109 | 4 | 1997 | 2020 | ||||||||
|
kinase insert domain receptor | 0.378 | 0.885 | 1.00 |
|
disease | 0.100 | None | 1.000 | 18 | 4 | 1995 | 2018 | ||||||||
|
vesicle transport through interaction with t-SNAREs 1A | 0.674 | 0.154 | 5.4E-04 |
|
disease | 0.120 | None | 1.000 | 3 | 4 | 2017 | 2018 | ||||||||
|
solute carrier family 7 member 7 | 0.603 | 0.654 | 8.0E-07 |
|
disease | 0.020 | None | 1.000 | 2 | 4 | 2013 | 2017 | ||||||||
|
isocitrate dehydrogenase (NADP(+)) 1 | 0.424 | 0.808 | 2.6E-12 |
|
disease | 0.700 | None | 0.984 | 373 | 3 | 2008 | 2020 | ||||||||
|
C-X-C motif chemokine receptor 4 | 0.362 | 0.923 | 1.8E-02 |
|
disease | 0.100 | None | 0.967 | 30 | 3 | 2002 | 2019 | ||||||||
|
ERCC excision repair 1, endonuclease non-catalytic subunit | 0.445 | 0.846 | 1.6E-07 |
|
disease | 0.100 | None | 0.900 | 20 | 3 | 1995 | 2017 | ||||||||
|
cyclin dependent kinase inhibitor 2B | 0.417 | 0.769 | 7.3E-03 |
|
disease | 0.700 | None | 0.882 | 17 | 3 | 1995 | 2019 | ||||||||
|
ERCC excision repair 2, TFIIH core complex helicase subunit | 0.420 | 0.846 | 7.1E-20 |
|
disease | 0.100 | None | 0.933 | 15 | 3 | 1995 | 2017 |